SCHEMBL20193871

SCHEMBL20193871

CC(C)(C)C1=CC2C=NNC2C=C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.34
ACACA Q13085 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14868891 0.86
SCHEMBL8285788 0.77 ACACB (0.33) ACACBACACA
SCHEMBL12670854 0.70
SCHEMBL12794619 0.68 ACACB (0.30) ACACBACACA
SCHEMBL22481662 0.67
SCHEMBL22792933 0.67
SCHEMBL25341653 0.67 ACACB (0.42) ACACBACACA
SCHEMBL24037448 0.63
SCHEMBL13438764 0.61
SCHEMBL24233749 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9981944-B2 GDF-8 inhibitors RIGEL PHARMACEUTICALS, INC (US) 2018-05-29 US disclosed